Back to search

Article

Gene editing is suitable to treat GM1 Gangliosidosis: a proof-of-concept study

2022-04-17

Abstract excerpt

Ganglioside-monosialic acid (GM1) gangliosidosis, a rare autosomal recessive disorder, is frequently caused by deleterious single nucleotide variants (SNVs) in GLB1 gene. These variants result in reduced β-galactosidase (β-gal) activity, leading to neurodegeneration associated with premature death. Currently, no effective therapy for GM1 gangliosidosis is available. Three ongoing clinical trials aim to deliver a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
716e38a4-e676-50bc-a4bb-979a8e74808b
DOI
10.1101/2022.04.17.488473
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Gene editing is suitable to treat GM1 Gangliosidosis: a proof-of-concept studyDOI 10.1101/2022.04.17.488473
Select a neighboring publication to make it the new centre.